NCT01085279

Fractional Laser as Treatment Option for Various Pigment Disorders (Fractional-3)

Non-ablative 1,550 nm Fractional Laser Therapy Versus Triple Topical Therapy for the Treatment of Melasma: a Randomized Controlled Split-face Study

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 29 (actual)
• Sponsor: Netherlands Institute for Pigment Disorders · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether the use of non-ablative fractional laser is safe and effective in the treatment of melasma.

Conditions

• Pigmentation Disorder

Interventions

Type	Name	Description
DEVICE	Fraxel Restore, Solta Medical Inc. (Non-ablative fractional laser)	1,550 nm non-ablative fractional laser Irradiance: 15 mJ/microbeam. Coverage: 14-20%. Number of treatment sessions: 4-5
DRUG	Modified Kligman's formula (Triple topical therapy)	Hydroquinone 5%, tretinoin 0.05%, triamcinolone acetonide 0.1% once a day during 15 weeks

Timeline

• Start date: 2009-03-01
• Primary completion: 2010-02-01
• Completion: 2010-02-01
• First posted: 2010-03-11
• Last updated: 2010-03-11

Locations

1 site across 1 country: Netherlands